The gut microbiome: Bridging medications and clinical outcomes post stem cell transplantation
- PMID: 37562360
- DOI: 10.1016/j.chom.2023.06.012
The gut microbiome: Bridging medications and clinical outcomes post stem cell transplantation
Abstract
Anti-cancer therapies are usually intertwined with prolonged use of drugs, which may lead to different clinical outcomes. Recently in Cell and Cell Host & Microbe, Nguyen et al. and Vallet et al., respectively, deconvolute the drug effects on gut microbiome dynamics underpinning clinical outcomes after allogeneic hematopoietic stem cell transplantation.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
MeSH terms
LinkOut - more resources
Full Text Sources
